The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck’s (NYSE:MRK) anti-cancer agent Welireg (belzutifan) ...

A panelist discusses how first-line treatment options for neuroendocrine tumors depend on tumor grade, disease extent, and symptoms, ranging from observation for asymptomatic cases to somatostatin ...

A panelist discusses how neuroendocrine tumors are defined by World Health Organization (WHO) classification, graded based on ...

Announcing a new publication for Acta Materia Medica journal. A preclinical study has developed a precision nano-intervention ...